GO:0016070 | RNA metabolic process | 21.93% (25/114) | 3.09 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 27.19% (31/114) | 2.64 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 15.79% (18/114) | 3.72 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 28.07% (32/114) | 2.37 | 0.0 | 0.0 |
GO:0005488 | binding | 66.67% (76/114) | 1.07 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 28.07% (32/114) | 2.25 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 28.07% (32/114) | 2.24 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 28.07% (32/114) | 2.21 | 0.0 | 0.0 |
GO:0005515 | protein binding | 35.09% (40/114) | 1.64 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 28.07% (32/114) | 1.95 | 0.0 | 0.0 |
GO:0043227 | membrane-bounded organelle | 14.91% (17/114) | 2.89 | 0.0 | 0.0 |
GO:0043231 | intracellular membrane-bounded organelle | 14.91% (17/114) | 2.89 | 0.0 | 0.0 |
GO:0005634 | nucleus | 13.16% (15/114) | 3.1 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 29.82% (34/114) | 1.72 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 79.82% (91/114) | 0.61 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 15.79% (18/114) | 2.61 | 0.0 | 0.0 |
GO:0043226 | organelle | 17.54% (20/114) | 2.25 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 17.54% (20/114) | 2.25 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 33.33% (38/114) | 1.24 | 0.0 | 4e-06 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4.39% (5/114) | 5.23 | 0.0 | 5e-06 |
GO:0097159 | organic cyclic compound binding | 38.6% (44/114) | 1.02 | 1e-06 | 2e-05 |
GO:0009451 | RNA modification | 6.14% (7/114) | 3.76 | 1e-06 | 2e-05 |
GO:0034470 | ncRNA processing | 6.14% (7/114) | 3.74 | 1e-06 | 2.1e-05 |
GO:0005575 | cellular_component | 28.95% (33/114) | 1.25 | 1e-06 | 2.4e-05 |
GO:0017056 | structural constituent of nuclear pore | 3.51% (4/114) | 5.44 | 2e-06 | 4e-05 |
GO:0042254 | ribosome biogenesis | 3.51% (4/114) | 5.44 | 2e-06 | 4e-05 |
GO:0006913 | nucleocytoplasmic transport | 4.39% (5/114) | 4.57 | 2e-06 | 4.1e-05 |
GO:0051169 | nuclear transport | 4.39% (5/114) | 4.53 | 3e-06 | 4.5e-05 |
GO:0006807 | nitrogen compound metabolic process | 33.33% (38/114) | 1.06 | 4e-06 | 6.2e-05 |
GO:0005643 | nuclear pore | 3.51% (4/114) | 5.23 | 4e-06 | 6.3e-05 |
GO:0009987 | cellular process | 42.98% (49/114) | 0.86 | 4e-06 | 6.4e-05 |
GO:0044085 | cellular component biogenesis | 4.39% (5/114) | 3.99 | 1.7e-05 | 0.000239 |
GO:0034660 | ncRNA metabolic process | 6.14% (7/114) | 3.13 | 1.7e-05 | 0.000246 |
GO:0016071 | mRNA metabolic process | 5.26% (6/114) | 3.31 | 3.5e-05 | 0.000452 |
GO:0016779 | nucleotidyltransferase activity | 5.26% (6/114) | 3.31 | 3.5e-05 | 0.000452 |
GO:0140098 | catalytic activity, acting on RNA | 7.02% (8/114) | 2.71 | 3.3e-05 | 0.000456 |
GO:0044238 | primary metabolic process | 35.09% (40/114) | 0.88 | 3.8e-05 | 0.000483 |
GO:0044237 | cellular metabolic process | 29.82% (34/114) | 0.98 | 5.2e-05 | 0.000644 |
GO:0008033 | tRNA processing | 3.51% (4/114) | 4.23 | 6.5e-05 | 0.000778 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 9.65% (11/114) | 2.02 | 8.8e-05 | 0.001032 |
GO:0140513 | nuclear protein-containing complex | 6.14% (7/114) | 2.72 | 0.000101 | 0.001124 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.63% (3/114) | 5.07 | 9.9e-05 | 0.001133 |
GO:0034061 | DNA polymerase activity | 2.63% (3/114) | 5.02 | 0.000109 | 0.001189 |
GO:0043414 | macromolecule methylation | 3.51% (4/114) | 3.96 | 0.000133 | 0.001353 |
GO:0001510 | RNA methylation | 2.63% (3/114) | 4.93 | 0.000131 | 0.001365 |
GO:0006260 | DNA replication | 4.39% (5/114) | 3.37 | 0.000129 | 0.00137 |
GO:0006397 | mRNA processing | 4.39% (5/114) | 3.33 | 0.000148 | 0.001472 |
GO:0016887 | ATP hydrolysis activity | 6.14% (7/114) | 2.62 | 0.000154 | 0.001497 |
GO:0071704 | organic substance metabolic process | 35.09% (40/114) | 0.78 | 0.000187 | 0.001784 |
GO:0000974 | Prp19 complex | 1.75% (2/114) | 6.44 | 0.000229 | 0.00214 |
GO:0110165 | cellular anatomical entity | 19.3% (22/114) | 1.15 | 0.000307 | 0.002814 |
GO:0032991 | protein-containing complex | 12.28% (14/114) | 1.52 | 0.000369 | 0.00326 |
GO:0032259 | methylation | 3.51% (4/114) | 3.58 | 0.000367 | 0.003307 |
GO:0006400 | tRNA modification | 2.63% (3/114) | 4.38 | 0.000416 | 0.003603 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 7.02% (8/114) | 2.06 | 0.000713 | 0.00607 |
GO:0008152 | metabolic process | 35.09% (40/114) | 0.69 | 0.000736 | 0.006148 |
GO:0008150 | biological_process | 51.75% (59/114) | 0.48 | 0.000972 | 0.007983 |
GO:0071840 | cellular component organization or biogenesis | 9.65% (11/114) | 1.59 | 0.001143 | 0.009222 |
GO:0016462 | pyrophosphatase activity | 7.02% (8/114) | 1.95 | 0.001166 | 0.009246 |
GO:0000152 | nuclear ubiquitin ligase complex | 1.75% (2/114) | 5.27 | 0.001226 | 0.009404 |
GO:0005680 | anaphase-promoting complex | 1.75% (2/114) | 5.27 | 0.001226 | 0.009404 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 7.02% (8/114) | 1.92 | 0.001306 | 0.009856 |
GO:0006259 | DNA metabolic process | 7.02% (8/114) | 1.92 | 0.001328 | 0.009868 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 7.02% (8/114) | 1.91 | 0.001387 | 0.009983 |
GO:0006399 | tRNA metabolic process | 3.51% (4/114) | 3.07 | 0.001371 | 0.010026 |
GO:0006606 | protein import into nucleus | 1.75% (2/114) | 5.04 | 0.001673 | 0.011686 |
GO:0034504 | protein localization to nucleus | 1.75% (2/114) | 5.04 | 0.001673 | 0.011686 |
GO:0031267 | small GTPase binding | 1.75% (2/114) | 4.98 | 0.001837 | 0.012107 |
GO:0051170 | import into nucleus | 1.75% (2/114) | 4.98 | 0.001837 | 0.012107 |
GO:0051020 | GTPase binding | 1.75% (2/114) | 4.98 | 0.001837 | 0.012107 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 2.63% (3/114) | 3.65 | 0.001819 | 0.012517 |
GO:0019899 | enzyme binding | 2.63% (3/114) | 3.6 | 0.002013 | 0.012906 |
GO:0005730 | nucleolus | 1.75% (2/114) | 4.91 | 0.002008 | 0.013051 |
GO:0009057 | macromolecule catabolic process | 4.39% (5/114) | 2.46 | 0.002259 | 0.014288 |
GO:0005739 | mitochondrion | 1.75% (2/114) | 4.79 | 0.002372 | 0.014801 |
GO:1902975 | mitotic DNA replication initiation | 0.88% (1/114) | 8.44 | 0.002886 | 0.016884 |
GO:0008479 | tRNA-guanosine(34) queuine transglycosylase activity | 0.88% (1/114) | 8.44 | 0.002886 | 0.016884 |
GO:1902315 | nuclear cell cycle DNA replication initiation | 0.88% (1/114) | 8.44 | 0.002886 | 0.016884 |
GO:1902292 | cell cycle DNA replication initiation | 0.88% (1/114) | 8.44 | 0.002886 | 0.016884 |
GO:0000493 | box H/ACA snoRNP assembly | 0.88% (1/114) | 8.44 | 0.002886 | 0.016884 |
GO:0006364 | rRNA processing | 2.63% (3/114) | 3.34 | 0.003358 | 0.0194 |
GO:0007005 | mitochondrion organization | 1.75% (2/114) | 4.48 | 0.003635 | 0.020748 |
GO:0016072 | rRNA metabolic process | 2.63% (3/114) | 3.25 | 0.003936 | 0.022195 |
GO:0072423 | response to DNA damage checkpoint signaling | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0072402 | response to DNA integrity checkpoint signaling | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0016428 | tRNA (cytidine-5-)-methyltransferase activity | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0009019 | obsolete tRNA (guanine-N1-)-methyltransferase activity | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0072396 | response to cell cycle checkpoint signaling | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0009933 | meristem structural organization | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0048532 | anatomical structure arrangement | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0071216 | cellular response to biotic stimulus | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0071495 | cellular response to endogenous stimulus | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0035266 | meristem growth | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0016427 | tRNA (cytidine) methyltransferase activity | 0.88% (1/114) | 7.44 | 0.005764 | 0.026976 |
GO:0008380 | RNA splicing | 2.63% (3/114) | 3.03 | 0.006021 | 0.027095 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 1.75% (2/114) | 4.27 | 0.004879 | 0.027184 |
GO:0046907 | intracellular transport | 4.39% (5/114) | 2.13 | 0.005884 | 0.027263 |
GO:0051649 | establishment of localization in cell | 4.39% (5/114) | 2.13 | 0.006008 | 0.027297 |
GO:0071826 | protein-RNA complex organization | 1.75% (2/114) | 4.11 | 0.005996 | 0.027509 |
GO:1990234 | transferase complex | 3.51% (4/114) | 2.55 | 0.005038 | 0.027741 |
GO:0008173 | RNA methyltransferase activity | 1.75% (2/114) | 4.08 | 0.006291 | 0.028041 |
GO:0000151 | ubiquitin ligase complex | 1.75% (2/114) | 4.04 | 0.006593 | 0.029111 |
GO:0022618 | protein-RNA complex assembly | 1.75% (2/114) | 4.19 | 0.005424 | 0.029517 |
GO:0070647 | protein modification by small protein conjugation or removal | 3.51% (4/114) | 2.35 | 0.008124 | 0.035533 |
GO:0000339 | RNA cap binding | 0.88% (1/114) | 6.85 | 0.008634 | 0.036077 |
GO:0005846 | nuclear cap binding complex | 0.88% (1/114) | 6.85 | 0.008634 | 0.036077 |
GO:0034518 | RNA cap binding complex | 0.88% (1/114) | 6.85 | 0.008634 | 0.036077 |
GO:0000491 | small nucleolar ribonucleoprotein complex assembly | 0.88% (1/114) | 6.85 | 0.008634 | 0.036077 |
GO:0019237 | centromeric DNA binding | 0.88% (1/114) | 6.85 | 0.008634 | 0.036077 |
GO:1901874 | negative regulation of post-translational protein modification | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:1904667 | negative regulation of ubiquitin protein ligase activity | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:0051382 | kinetochore assembly | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:0051383 | kinetochore organization | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:0031397 | negative regulation of protein ubiquitination | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 0.88% (1/114) | 6.44 | 0.011495 | 0.044097 |
GO:0006401 | RNA catabolic process | 1.75% (2/114) | 3.66 | 0.011099 | 0.045965 |
GO:0140535 | intracellular protein-containing complex | 3.51% (4/114) | 2.21 | 0.011207 | 0.046007 |